CALCITONIN (THYROCALCITONIN)

CALCITONIN (THYROCALCITONIN) is a quantitative blood test that measures the level of calcitonin, a hormone produced by thyroid parafollicular C‑cells. Measured by a sensitive immunoassay on a venous serum sample, calcitonin is an important biomarker used to detect and monitor medullary thyroid carcinoma (MTC) and other C‑cell related disorders.

This test is commonly used for screening individuals with thyroid nodules, carriers or relatives of RET mutation/MEN2 patients, and for post‑operative surveillance after treatment for MTC. At‑home collection by a certified phlebotomist with fast laboratory processing across Dubai and the UAE makes testing convenient; however, results should be interpreted by an endocrinologist or oncology specialist because factors such as smoking, certain medications, renal failure, and neuroendocrine conditions can affect levels.

• Calcitonin (Serum - Basal)
• Calcitonin (Serum - Stimulated, if requested)
• Sample type: Venous blood (Serum)
• Quantitative calcitonin assay (reported in pg/mL or ng/L)

• Evaluation of thyroid nodules or suspicious thyroid ultrasound findings
• Family history of medullary thyroid carcinoma or known RET/MEN2 mutation
• Post‑operative monitoring for residual or recurrent MTC
• Screening of RET mutation carriers or at‑risk relatives
• Unexplained C‑cell hyperplasia, persistent hypercalcitoninemia, or relevant neuroendocrine suspicion

• At‑home venous blood collection by certified phlebotomists across Dubai & the UAE
• Fast laboratory processing with quantitative, high‑sensitivity assay
• Convenient screening and reliable monitoring for medullary thyroid carcinoma
• Clinical interpretation and follow‑up recommendations available from specialists
• Reduced need for hospital visits—suitable for routine surveillance and initial evaluation

• At‑home venous blood sample collection by a trained phlebotomist
• No strict fasting required; avoid smoking and vigorous exercise for 2–4 hours before the test
• Notify the phlebotomist/physician about medications (e.g., proton pump inhibitors, calcium supplements) and recent procedures that may affect results
• Stimulated calcitonin testing (when indicated) requires a clinic visit and specific preparation per protocol